Search
for
Sort by
Research 121–150 of 782
- Oxidative stress: Insights into the Pathogenesis and Treatment of Alopecia
- Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Effect of a medicinal and edible decoction YH0618 on chemotherapy-induced dermatologic toxicity: a randomized controlled trial
- Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia
- Next generation human skin constructs as advanced tools for drug development
- Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature
- The financial burden of scalp cooling therapy: A nonprofit organization data analysis
- Optimizing hair care products and practices for Black patients with breast cancer: One size does not fit all
- Low-Dose Oral Minoxidil During Chemotherapy: A Review of the Mechanism and Current Evidence
- 28-Year-Old Female with Diffuse Thinning of the Scalp after Isotretinoin and Oral Contraceptives
- Food Bioactive Compounds and Emerging Techniques for Their Extraction: Polyphenols as a Case Study
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Chinese Herbal Medicine for Reducing Chemotherapy-Associated Side-Effects in Breast Cancer Patients: A Systematic Review and Meta-Analysis
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling
- Dermatologic Adverse Events from Cancer Treatments
- Optimizing Scalp Cooling: (Ultra)Structural Follicular Characteristic and Restorative Advances
- Hair & Cutaneous Development
- Mucocutaneous reactions to chemotherapy
- Cutaneous complications of chemotherapeutic agents
- Repurposing of Various Current Medicines as Radioprotective Agents
- DRUG‐ASSOCIATED ALOPECIA
- Mitoxantrone
- Alopecia - the search for novel agents continues
- Mild oxidative stress protects against chemotherapy-induced hair loss
- Hair Changes due to Drugs
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Clinical Development of Topoisomerase-Interactive Drugs
- Cutaneous Reactions to Drugs